Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Digital Biomarkers Market’s Growth Rate Evolve Over the Forecast Period to 2034?

In recent times, the digital biomarkers market has seen exponential growth. It is predicted to expand from $3.92 billion in 2024 to $4.96 billion in 2025, with a compound annual growth rate (CAGR) of 26.3%. Factors contributing to this surge during the historical period include the proliferation of mobile health applications, early utilization in clinical trials, increased occurrence of chronic illness, growing interest in fitness and wellness among consumers, and the rise in healthcare digitization.

The market size for digital biomarkers is anticipated to witness substantial expansion in the coming years. It is projected to reach a valuation of $12.52 billion by 2029, growing at a Compounded Annual Growth Rate (CAGR) of 26.1%. The projected growth in this timeframe is attributed to the rising adoption by healthcare providers, increasing incidence of chronic illnesses, heightened consumer awareness, and a growing interest in fitness and lifestyle monitoring among consumers. Major trends expected during this forecast period includes progress in wearable technology, amalgamation with artificial intelligence, collaborations and partnerships, growth in emerging markets, and integration with electronic health records.

What Industry-Specific Factors Are Fueling the Growth of the Digital Biomarkers Market?

The escalating rates of chronic illnesses are anticipated to spur the expansion of the digital biomarkers industry. Chronic conditions, usually slow in progression and enduring for a long period or even a lifetime, tend to intensify with age-related disorders such as osteoarthritis, Alzheimer’s, and heart disease. Factors such as high consumption of processed food and decreased physical exertion also amplify the chances of chronic diseases. The role of digital biomarkers in chronic illnesses is to track health indicators and the advancement of the disease in real time, allowing for more personalized and instant interventions. For example, as per the data released by the US government organization, Centers for Disease Control and Prevention (CDC.gov), in May 2023, the number of deaths due to heart disease and cancer amounted to 6,95,547 in 2022, showing an escalation from 6,05,213 in the previous year. Hence, the increasing prevalence of chronic diseases is set to drive the expansion of the digital biomarker industry.

Request Your Free Digital Biomarkers Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=19397&type=smp

Who Are the Influential Players Reshaping the Digital Biomarkers Market Landscape?

Major companies operating in the digital biomarkers market are Pfizer Inc., Bayer AG, F Hoffmann-La Roche Ltd., Eli Lilly and Company, Koninklijke Philips NV (Philips), GE Healthcare, Biogen Inc., Garmin Ltd., Clario, Verily Life Sciences LLC, Altoida Inc., BioSerenity, Oura Health Oy., Evidation Health Inc., AliveCor Inc., Empatica Inc., ActiGraph LLC, VivoSense Inc., BioSensics LLC, Koneksa Health Inc., ATCOR Medical Pty Ltd., Brainomix Limited

What New and Evolving Trends Are Having a Lasting Impact on the Digital Biomarkers Market?

Top firms functioning in the digital biomarker arena are turning to strategic partnerships as a means to broaden their scope and improve their services. A strategic partnership typically signifies a cooperative relationship between two or more entities which pool their resources, skills, and endeavors to reach shared goals or targets. For example, in September 2023, ProofPilot, an American enterprise specializing in clinical trial automation, established a strategic alliance with Eli Lilly and Company, an American pharmaceutical firm. This partnership was in order to incorporate Lilly’s ground-breaking, patent-pending sensor cloud platform, Magnol.AI, into the technology package of ProofPilot. Magnol.AI is an advanced platform engineered to efficiently and securely handle high-frequency sensor data. The objective of this partnership is to augment the delivery of top-quality digital health research, and hasten non-competitive biomedical research. This incorporation lets researchers exploit real-time data science capabilities and procure valuable insights from sensor data, lining up with clinician and patient-reported results to promote digital health and biomarker studies.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/digital-biomarkers-global-market-report

Which Segments of the Digital Biomarkers Market Hold the Most Potential for Future Development?

The digital biomarkersmarket covered in this report is segmented –

1) By Type: Wearable, Mobile Based Applications, Sensors, Other Types

2) By Clinical Practice: Diagnostic Digital Biomarkers, Monitoring Digital Biomarkers, Predictive And Prognostic Digital Biomarkers, Other Clinical Practices

3) By Application: Oncology, Metabolic Disease, Neurological Disease, Cardiac Disease, Other Applications

4) By End User: Healthcare Companies, Healthcare Providers, Payers, Other End Users

Subsegments:

1) By Wearable: Smartwatches, Fitness Trackers, Wearable ECG Monitors, Continuous Glucose Monitors

2) By Mobile Based Applications: Health Monitoring Apps, Digital Therapeutics Apps, Symptom Tracking Apps, Remote Patient Monitoring Apps

3) By Sensors: Biosensors, Motion Sensors, Environmental Sensors, Implantable Sensors

4) By Other Types: Voice Biomarkers, Digital Imaging Biomarkers, Behavioral Biomarkers, Telemedicine Tools

Which Geographic Locations Are Critical to the Growth of the Digital Biomarkers Market?

North America was the largest region in the digital biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Aspects of the Digital Biomarkers Market Landscape?

Digital biomarkers are objective, quantifiable physiological and behavioral data that are collected and measured using digital devices such as wearables, sensors, and mobile health applications. They are used to monitor and predict health outcomes, enabling more precise and personalized medical interventions. These biomarkers enable continuous and real-time health monitoring, leading to more personalized medical interventions and improved disease management.

Browse Through More Similar Reports By The Business Research Company:

Digital Payments Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digital-payments-global-market-report

Digital Publishing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digital-publishing-global-market-report

Digital Advertising Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/digital-advertising-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: